Skip to main content
. Author manuscript; available in PMC: 2020 Apr 13.
Published in final edited form as: Clin Exp Rheumatol. 2019 Sep 17;37(Suppl 119):97–101.

Table 2:

Vascular Reactivity Index With Clinical and Demographic Characteristics

Variable Correlation Coefficient or Mean ± SD P-value
Age* Spearman’s rho = −.32 p=0.08
Modified Rodnan Skin Score * Spearman’s rho =−0.06 p=0.7
Duration of SSc (first non-Raynaud symptom)* Spearman’s rho =−0.25 p= 0.15
History of Scleroderma Renal Crisis**
 Yes 0.58 ± 0.46
 No 0.88 ± 0.54 p=0.31
Current Scleroderma Renal Crisis**
Yes 0.59 ± 0.46
No 0.90 ± 0.56 p =0.31
History of Pulmonary Artery Hypertension**
 Yes 0.75 ± 0.48
 No 0.85 ± 0.54 p=0.80
Current Pulmonary Artery Hypertension**
Yes 0.70 ± 0.46
No 0.95 ± 0.56 p = 0.34
History of Digital Tip Ulcer** p =0.41
Yes 0.74 ± 0.58
No 0.91 ± 0.50,
Current ILD** p=0.96
Yes 0.86 ± 0.62
No 0.85 ± 0.43,
Smoking** p= 0.59
 Never 0.78 ± 0.56
 In the past or current 0.88 ± 0.52
Vasodilator therapy ** p = 0.52
 Calcium Channel Blockers 0.73 ± 0.48
 Other 0.86 ± 0.56
Gastrointestinal medications** 0.74 ± 0.44 P=0.42
0.89 ± 0.61
*

Spearman’s Rho,

**

Mean ± standard deviation;